MedTrace Logo

Mental Health and Suicidality in Glioblastoma Patients in Germany

NCT07409584 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 176

Last updated 2026-05-18

No results posted yet for this study

Summary

The aim of the study is to use standardized questionnaires to systematically record influencing factors or predictors for suicidal behavior in glioblastoma patients, particularly with regard to existing depression and anxiety symptoms.

Conditions

  • Glioblastoma (GBM)

Interventions

DIAGNOSTIC_TEST

Medical history, physical examination, completing questionnaires, data collection

Medical history Physical examination Completion of validated questionnaires: * Suicide Scale (SSEV) * Patient Health Questionnaire-8 (PHQ-8) * Generalized Anxiety Disorder-7 (GAD-7) * EORTC-QLQ-30 * EORTC-QLQ-BN-20 * Short questionnaire on social support for chronic illnesses (SUCE-4) Data collection from medical records

Sponsors & Collaborators

  • University Hospital Muenster

    collaborator OTHER

  • Charite University, Berlin, Germany

    collaborator OTHER

  • University Hospital Heidelberg

    collaborator OTHER

  • Neurological Clinic, Knappschaftskrankenhaus Bochum-Langendreer, Bochum, Germany

    collaborator UNKNOWN

  • Universitätsklinikum Hamburg-Eppendorf

    collaborator OTHER

  • University Hospital, Essen

    lead OTHER

Principal Investigators

  • Sied Kebir, PD Dr. med. · University Hospital, Essen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-18
Primary Completion
2027-02-28
Completion
2027-12-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07409584 on ClinicalTrials.gov